Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_assertion type Assertion NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_head.
- NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_assertion description "[Besides BCR-ABL and SRC kinases, stem cell pathways must be targeted for curative therapy of Ph(+) leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_provenance.
- NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_assertion evidence source_evidence_literature NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_provenance.
- NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_assertion SIO_000772 17077147 NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_provenance.
- NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_assertion wasDerivedFrom befree-20140225 NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_provenance.
- NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_assertion wasGeneratedBy ECO_0000203 NP638038.RAuFAvI0EJ53Vya0WkfaKwp7wSLUMexzrz4TzMRJ6wEH4130_provenance.